DK1398A - Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse - Google Patents

Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse

Info

Publication number
DK1398A
DK1398A DK199800013A DK1398A DK1398A DK 1398 A DK1398 A DK 1398A DK 199800013 A DK199800013 A DK 199800013A DK 1398 A DK1398 A DK 1398A DK 1398 A DK1398 A DK 1398A
Authority
DK
Denmark
Prior art keywords
compound
preparation
antifungal agent
antifungal
agent
Prior art date
Application number
DK199800013A
Other languages
English (en)
Other versions
DK176599B1 (da
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Mananori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of DK1398A publication Critical patent/DK1398A/da
Application granted granted Critical
Publication of DK176599B1 publication Critical patent/DK176599B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK199800013A 1995-07-08 1998-01-07 Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse DK176599B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same
JP9601872 1996-07-05

Publications (2)

Publication Number Publication Date
DK1398A true DK1398A (da) 1998-01-07
DK176599B1 DK176599B1 (da) 2008-10-27

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199800013A DK176599B1 (da) 1995-07-08 1998-01-07 Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse

Country Status (22)

Country Link
US (1) US5900488A (da)
EP (1) EP0839035B1 (da)
KR (1) KR100386491B1 (da)
CN (1) CN1091596C (da)
AT (1) AT407832B (da)
CA (1) CA2226214C (da)
CH (1) CH692045A5 (da)
DE (1) DE19681478B4 (da)
DK (1) DK176599B1 (da)
ES (1) ES2137888B1 (da)
FI (1) FI119357B (da)
GB (1) GB2317615B (da)
HK (1) HK1009751A1 (da)
IL (1) IL122618A (da)
IN (1) IN185384B (da)
LU (1) LU90190B1 (da)
NO (1) NO980055L (da)
NZ (1) NZ311796A (da)
SE (1) SE9800016D0 (da)
TW (1) TW450969B (da)
WO (1) WO1997002821A2 (da)
ZA (1) ZA965745B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
US8039452B2 (en) * 2002-06-18 2011-10-18 Pola Pharma Inc. Antifungal medicinal compositions
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
AU2006339842B2 (en) 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
EP2191825B8 (en) 2007-08-27 2016-09-21 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis
WO2009031644A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌医薬組成物
JP5529539B2 (ja) * 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
EP2745692A1 (en) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
RU2622644C2 (ru) * 2012-09-14 2017-06-19 Пола Фарма Инк. Кристаллическое вещество и содержащий его фармацевтический препарат
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
EP2895479A1 (en) * 2012-09-14 2015-07-22 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
CN104968344A (zh) * 2013-01-28 2015-10-07 宝丽制药股份有限公司 针对由病原微生物诸如念珠菌引起的疾病的药物组合物
JP6279583B2 (ja) * 2013-01-28 2018-02-14 株式会社ポーラファルマ アスペルギルス等の病原微生物による疾患用の医薬組成物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
AR100180A1 (es) * 2014-04-25 2016-09-14 Syngenta Participations Ag Derivados de imidazol microbiocidas
WO2016092478A1 (en) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
TW450969B (en) 2001-08-21
NO980055L (no) 1998-03-06
DK176599B1 (da) 2008-10-27
ES2137888A1 (es) 1999-12-16
GB9726766D0 (en) 1998-02-18
FI119357B (fi) 2008-10-31
DE19681478B4 (de) 2006-09-21
NZ311796A (en) 1999-06-29
LU90190B1 (de) 1998-03-02
HK1009751A1 (en) 1999-06-11
ES2137888B1 (es) 2001-01-01
DE19681478T1 (de) 1998-07-02
EP0839035B1 (en) 2002-10-02
CH692045A5 (de) 2002-01-15
FI980023A0 (fi) 1998-01-07
AU697571B2 (en) 1998-10-08
AT407832B (de) 2001-06-25
CA2226214A1 (en) 1997-01-30
SE9800016L (sv) 1998-01-07
US5900488A (en) 1999-05-04
MX9710401A (es) 1998-07-31
NO980055D0 (no) 1998-01-06
IN185384B (da) 2001-01-13
ZA965745B (en) 1997-01-27
FI980023A (fi) 1998-01-07
IL122618A0 (en) 1998-08-16
GB2317615A (en) 1998-04-01
KR19990028772A (ko) 1999-04-15
EP0839035A2 (en) 1998-05-06
KR100386491B1 (ko) 2003-08-21
CA2226214C (en) 2007-04-17
CN1091596C (zh) 2002-10-02
ATA906196A (de) 2000-11-15
CN1194582A (zh) 1998-09-30
WO1997002821A2 (en) 1997-01-30
GB2317615B (en) 1998-09-02
SE9800016D0 (sv) 1998-01-07
AU6319296A (en) 1997-02-10
WO1997002821A3 (en) 1997-02-20
IL122618A (en) 2002-07-25

Similar Documents

Publication Publication Date Title
DK1398A (da) Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse
IS4483A (is) Nýtt segavarnarlyf, aðferð við framleiðslu þess og notkun
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO950425D0 (no) Antifungale midler, fremgangsmåter for fremstilling av disse, og mellomprodukter
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
DK0815130T3 (da) Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO961071D0 (no) Kjemiske forbindelser, deres fremstilling og anvendelse
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
DK0998473T3 (da) Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse
NO20003070D0 (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
DK91793A (da) Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
NO893748D0 (no) Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling.
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DK0805797T3 (da) Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer
DK432289D0 (da) Vandfortyndbart, lufttoerende belaegningsmiddel og dets anvendelse
NO990913L (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
DK60593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK1061955T3 (da) Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf
NO975415L (no) Basiske koboltholdige karbonater, fremgangsmåte for fremstilling og anvendelse derav
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
PUP Patent expired

Expiry date: 20180107